1. Home
  2. MEG vs KALV Comparison

MEG vs KALV Comparison

Compare MEG & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEG
  • KALV
  • Stock Information
  • Founded
  • MEG 2012
  • KALV N/A
  • Country
  • MEG United States
  • KALV United States
  • Employees
  • MEG N/A
  • KALV N/A
  • Industry
  • MEG Professional Services
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEG Consumer Discretionary
  • KALV Health Care
  • Exchange
  • MEG Nasdaq
  • KALV Nasdaq
  • Market Cap
  • MEG 985.6M
  • KALV 796.4M
  • IPO Year
  • MEG 2020
  • KALV N/A
  • Fundamental
  • Price
  • MEG $28.90
  • KALV $11.36
  • Analyst Decision
  • MEG Buy
  • KALV Strong Buy
  • Analyst Count
  • MEG 6
  • KALV 8
  • Target Price
  • MEG $32.50
  • KALV $26.43
  • AVG Volume (30 Days)
  • MEG 434.9K
  • KALV 1.4M
  • Earning Date
  • MEG 11-05-2025
  • KALV 09-11-2025
  • Dividend Yield
  • MEG N/A
  • KALV N/A
  • EPS Growth
  • MEG N/A
  • KALV N/A
  • EPS
  • MEG N/A
  • KALV N/A
  • Revenue
  • MEG $780,122,000.00
  • KALV $1,426,000.00
  • Revenue This Year
  • MEG $18.02
  • KALV N/A
  • Revenue Next Year
  • MEG $3.50
  • KALV $209.38
  • P/E Ratio
  • MEG N/A
  • KALV N/A
  • Revenue Growth
  • MEG 17.79
  • KALV N/A
  • 52 Week Low
  • MEG $10.51
  • KALV $7.30
  • 52 Week High
  • MEG $32.00
  • KALV $17.28
  • Technical
  • Relative Strength Index (RSI)
  • MEG 54.85
  • KALV 38.73
  • Support Level
  • MEG $27.12
  • KALV $10.69
  • Resistance Level
  • MEG $29.85
  • KALV $12.00
  • Average True Range (ATR)
  • MEG 1.10
  • KALV 0.57
  • MACD
  • MEG -0.09
  • KALV -0.07
  • Stochastic Oscillator
  • MEG 72.16
  • KALV 25.92

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: